explore
Previous article:
How to save PrEP access — and even expand it
Next article: Alnylam reports growth in sales of rare disease treatments
Next article: Alnylam reports growth in sales of rare disease treatments
hotspot
focus
-
In the gardens at Boston Children's Hospital, families find sanctuary
2025-09-28 22:14 -
What to watch for from Zogenix and Amicus clinical trials
2025-09-28 22:04 -
'Null' research findings aren't empty of meaning. Let's publish them
2025-09-28 21:34 -
Will the FTC rein in IQVIA's health data empire?
2025-09-28 21:05 -
2 officers injured in shooting in Orlando, police say
2025-09-28 20:29 -
Group behind ProMed defends move to subscription
2025-09-28 20:17